临床前1 T PET/MRI在大鼠中的弥散加权成像方案建立与肿瘤监测应用
本研究在18只健康大鼠肝脏中比较不同b值组合的ADC测量,建立适用于临床前1 T PET/MRI的呼吸门控DWI方案,并用该方案纵向监测5只原位肝细胞癌大鼠(其中3只附加FDG-PET),发现b=0、200、300 s/mm²组合与四b值参考测量一致性最高,肿瘤ADC随时间下降并与FDG-PET所见肿瘤增大及摄取异质性平行。
要点
- b=0、200、300 s/mm²组合与四b值参考测量相关性最高(rs=0.92)且缩短采集时间。
- 少于四个b值测量所得ADC显著偏高(p<0.001)。
- 该方案可纵向监测原位肝细胞癌ADC变化,并与FDG-PET及病理炎症所见平行。
核心结论
- 建立了适用于临床前1 T PET/MRI扫描仪的呼吸门控DWI方案,可监测原位肝细胞癌生长相关的ADC变化。
- 通过纵向监测肿瘤ADC变化可描述不同细胞阶段,但每项研究需根据自身问题进一步调整方案。
研究设计与样本
- 先在18只健康大鼠肝脏中比较不同b值组合计算的ADC与四b值(0、100、200、300 s/mm²)参考测量的一致性。
- 随后用T2加权MRI与优化DWI监测5只原位肝细胞癌大鼠,其中3只额外行FDG-PET成像,ADC经组织病理学验证。
主要发现
- 与参考测量相比,b=0、200、300 s/mm²组合的相关系数最高(rs=0.92)且一致性最好,同时缩短采集时间。
- 少于四个b值的测量所得ADC显著高于参考(p<0.001)。
- 监测肝细胞癌时观察到ADC随时间下降,FDG-PET显示肿瘤增大及摄取异质性增加。
- 周围肝实质ADC亦发生变化,免疫组化显示不同水平炎症。
关键数值与推荐
- 健康大鼠肝脏DWI使用扫描仪依赖的最大4个b值:0、100、200、300 s/mm²。
- 优化方案为b=0、200、300 s/mm²,与四b值参考测量相关系数rs=0.92。
- 少于四个b值测量的ADC显著偏高,p<0.001。
临床怎么用
- 在临床前1 T PET/MRI行大鼠肝脏DWI时可优先采用b=0、200、300 s/mm²的呼吸门控方案以兼顾准确性与采集时间。
- 纵向监测肝细胞癌ADC变化可辅助描述肿瘤细胞阶段,但需结合FDG-PET与病理炎症信息综合解读。
- 各研究应根据自身科学问题进一步调整DWI协议以获得最佳结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hybrid positron emission tomography and magnetic resonance imaging (PET/MRI) scanners are increasingly used for both clinical and preclinical imaging. Especially functional MRI sequences such as diffusion-weighted imaging (DWI) are of great interest as they provide information on a molecular level, thus, can be used as surrogate biomarkers. Due to technical restrictions, MR sequences need to be adapted for each system to perform reliable imaging. There is, to our knowledge, no suitable DWI protocol for 1 Tesla PET/MRI scanners. We aimed to establish such DWI protocol with focus on the choice of b values, suitable for longitudinal monitoring of tumor characteristics in a rat liver tumor model. MATERIAL AND METHODS: DWI was first performed in 18 healthy rat livers using the scanner-dependent maximum of 4 b values (0, 100, 200, 300 s/mm2). Apparent diffusion coefficients (ADC) were calculated from different b value combinations and compared to the reference measurement with four b values. T2-weighted MRI and optimized DWI with best agreement between accuracy, scanning time, and system performance stability were used to monitor orthotopic hepatocellular carcinomas (HCC) in five rats of which three underwent additional 2-deoxy-2-(18F)fluoro-D-glucose(FDG)-PET imaging. ADCs were calculated for the tumor and the surrounding liver parenchyma and verified by histopathological analysis. RESULTS: Compared to the reference measurements, the combination b = 0, 200, 300 s/mm2 showed the highest correlation coefficient (rs = 0.92) and agreement while reducing the acquisition time. However, measurements with less than four b values yielded significantly higher ADCs (p < 0.001). When monitoring the HCC, an expected drop of the ADC was observed over time. These findings were paralleled by FDG-PET showing both an increase in tumor size and uptake heterogeneity. Interestingly, surrounding liver parenchyma also showed a change in ADC values revealing varying levels of inflammation by immunohistochemistry. CONCLUSION: We established a respiratory-gated DWI protocol for a preclinical 1 T PET/MRI scanner allowing to monitor growth-related changes in ADC values of orthotopic HCC liver tumors. By monitoring the changes in tumor ADCs over time, different cellular stages were described. However, each study needs to adapt the protocol further according to their question to generate best possible results.
引用
- Albrecht J, Polenz D, Kühl AA, et al. Diffusion-weighted magnetic resonance imaging using a preclinical 1 T PET/MRI in healthy and tumor-bearing rats. EJNMMI Res. 2019. PMID: 30796555. doi:10.1186/s13550-019-0489-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。